Brief: Apyx Medical Corporation Receives FDA Clearance For The Use Of Renuvion To Coagulate And Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed

Apyx Medical

27/02/2023 13:00

Feb 27 (Reuters) - Apyx Medical Corp  APYX.O :
    * APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR
THE
USE OF RENUVION® TO COAGULATE AND CONTRACT SOFT TISSUES,
INCLUDING SUBCUTANEOUS TISSUE, WHERE NEEDED

Source text for Eikon:  ID:nBw3Gt4zBa 
Further company coverage:  APYX.O 

 ((Reuters.Briefs@thomsonreuters.com))